Cargando…
Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States
BACKGROUND: Payments from pharmaceutical drug manufacturers to authors of clinical practice guidelines (CPGs) may have an impact on their recommendations. In this study, we aimed to evaluate the accuracy of financial conflict of interest (FCOI) declarations among authors of Inflammatory Bowel Diseas...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656332/ https://www.ncbi.nlm.nih.gov/pubmed/34755712 http://dx.doi.org/10.4103/sjg.sjg_426_21 |